However, sustained activation caused CD19 CAR-T cells to enter a depleted state, with increased inhibitory receptors PD1 and CTLA4, and significantly increased in the markers of exhaustion CD244 and CD160, and weakened their anti-tumor activity (19). Here, CD19 is linked to neoplasm.